3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Stomach Neoplasms
3
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Pleuropulmonary blastoma
1
Patient Preference
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
HER2-positive Breast Cancer
1
HER2 Positive Breast Cancer
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
fludarabine phosphate
36
Whole-Body Irradiation
30
Cyclophosphamide
30
Mycophenolic Acid
28
Azacitidine
27
Tacrolimus
25
Peripheral Blood Stem Cell Transplantation
24
Busulfan
22
Methotrexate
15
Cyclosporine
15
Antilymphocyte Serum
14
Decitabine
11
Cytarabine
11
Melphalan
10
fludarabine
9
Radiotherapy
8
Filgrastim
8
Granulocyte Colony-Stimulating Factor
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
thymoglobulin
6
Sirolimus
6
Rituximab
6
Cyclosporins
6
Clofarabine
6
venetoclax
5
merphos
5
Sorafenib
4
Lenalidomide
4
Injections
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelomonocytic, Chronic
×
Ado-Trastuzumab Emtansine
×
Clear all
No trials found.